Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Related studies linked through entity extraction aliases.